vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and PagerDuty, Inc. (PD). Click either name above to swap in a different company.
PagerDuty, Inc. is the larger business by last-quarter revenue ($124.5M vs $75.5M, roughly 1.7× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 4.7%). PagerDuty, Inc. produced more free cash flow last quarter ($24.1M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 5.9%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.
PBYI vs PD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $124.5M |
| Net Profit | — | $161.6M |
| Gross Margin | 69.3% | 85.3% |
| Operating Margin | 22.7% | 6.5% |
| Net Margin | — | 129.7% |
| Revenue YoY | 27.7% | 4.7% |
| Net Profit YoY | — | 2827.7% |
| EPS (diluted) | $0.26 | $1.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $124.5M | ||
| Q3 25 | $54.5M | $123.4M | ||
| Q2 25 | $52.4M | $119.8M | ||
| Q1 25 | $46.0M | $121.4M | ||
| Q4 24 | $59.1M | $118.9M | ||
| Q3 24 | $80.5M | $115.9M | ||
| Q2 24 | $47.1M | $111.2M | ||
| Q1 24 | $43.8M | $111.1M |
| Q4 25 | — | $161.6M | ||
| Q3 25 | $8.8M | $9.6M | ||
| Q2 25 | $5.9M | $-7.2M | ||
| Q1 25 | $3.0M | $-8.8M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | $20.3M | $-10.9M | ||
| Q2 24 | $-4.5M | $-17.1M | ||
| Q1 24 | $-4.8M | $-28.2M |
| Q4 25 | 69.3% | 85.3% | ||
| Q3 25 | 77.7% | 84.6% | ||
| Q2 25 | 76.5% | 84.0% | ||
| Q1 25 | 77.1% | 83.6% | ||
| Q4 24 | 76.4% | 83.0% | ||
| Q3 24 | 63.9% | 82.7% | ||
| Q2 24 | 77.4% | 82.6% | ||
| Q1 24 | 75.5% | 81.7% |
| Q4 25 | 22.7% | 6.5% | ||
| Q3 25 | 17.6% | 2.9% | ||
| Q2 25 | 12.7% | -8.6% | ||
| Q1 25 | 8.7% | -9.6% | ||
| Q4 24 | 22.6% | -8.7% | ||
| Q3 24 | 27.4% | -13.8% | ||
| Q2 24 | -4.6% | -19.5% | ||
| Q1 24 | -5.3% | -30.1% |
| Q4 25 | — | 129.7% | ||
| Q3 25 | 16.2% | 7.8% | ||
| Q2 25 | 11.2% | -6.0% | ||
| Q1 25 | 6.5% | -7.2% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | 25.2% | -9.4% | ||
| Q2 24 | -9.6% | -15.4% | ||
| Q1 24 | -11.0% | -25.3% |
| Q4 25 | $0.26 | $1.69 | ||
| Q3 25 | $0.17 | $0.10 | ||
| Q2 25 | $0.12 | $-0.07 | ||
| Q1 25 | $0.06 | $-0.12 | ||
| Q4 24 | $0.40 | $-0.07 | ||
| Q3 24 | $0.41 | $-0.14 | ||
| Q2 24 | $-0.09 | $-0.26 | ||
| Q1 24 | $-0.10 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $547.8M |
| Total DebtLower is stronger | $22.7M | — |
| Stockholders' EquityBook value | $130.3M | $320.5M |
| Total Assets | $216.3M | $1.0B |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $547.8M | ||
| Q3 25 | $94.4M | $567.9M | ||
| Q2 25 | $96.0M | $597.1M | ||
| Q1 25 | $93.2M | $570.8M | ||
| Q4 24 | $101.0M | $542.2M | ||
| Q3 24 | $96.7M | $599.3M | ||
| Q2 24 | $96.8M | $592.8M | ||
| Q1 24 | $107.2M | $571.2M |
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | $484.5M | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | $489.5M |
| Q4 25 | $130.3M | $320.5M | ||
| Q3 25 | $115.3M | $180.7M | ||
| Q2 25 | $104.7M | $145.7M | ||
| Q1 25 | $97.1M | $129.8M | ||
| Q4 24 | $92.1M | $111.6M | ||
| Q3 24 | $71.1M | $164.7M | ||
| Q2 24 | $48.5M | $174.0M | ||
| Q1 24 | $51.0M | $171.6M |
| Q4 25 | $216.3M | $1.0B | ||
| Q3 25 | $202.9M | $891.5M | ||
| Q2 25 | $194.9M | $926.8M | ||
| Q1 25 | $196.2M | $927.3M | ||
| Q4 24 | $213.3M | $866.8M | ||
| Q3 24 | $220.7M | $916.0M | ||
| Q2 24 | $205.0M | $924.0M | ||
| Q1 24 | $214.1M | $925.3M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | 3.73× | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | 2.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $24.8M |
| Free Cash FlowOCF − Capex | $14.4M | $24.1M |
| FCF MarginFCF / Revenue | 19.1% | 19.3% |
| Capex IntensityCapex / Revenue | 0.0% | 0.6% |
| Cash ConversionOCF / Net Profit | — | 0.15× |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $24.8M | ||
| Q3 25 | $9.7M | $34.0M | ||
| Q2 25 | $14.1M | $30.7M | ||
| Q1 25 | $3.6M | $31.4M | ||
| Q4 24 | $15.6M | $22.1M | ||
| Q3 24 | $11.0M | $35.8M | ||
| Q2 24 | $1.0M | $28.6M | ||
| Q1 24 | $11.2M | $22.2M |
| Q4 25 | $14.4M | $24.1M | ||
| Q3 25 | $9.7M | $33.1M | ||
| Q2 25 | $14.1M | $30.2M | ||
| Q1 25 | $3.6M | $30.3M | ||
| Q4 24 | $15.6M | $21.5M | ||
| Q3 24 | $11.0M | $35.1M | ||
| Q2 24 | $1.0M | $28.2M | ||
| Q1 24 | — | $21.2M |
| Q4 25 | 19.1% | 19.3% | ||
| Q3 25 | 17.7% | 26.8% | ||
| Q2 25 | 26.8% | 25.2% | ||
| Q1 25 | 7.7% | 24.9% | ||
| Q4 24 | 26.4% | 18.1% | ||
| Q3 24 | 13.7% | 30.3% | ||
| Q2 24 | 2.1% | 25.4% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 0.0% | 0.6% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.1% | 0.9% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.0% | 0.9% |
| Q4 25 | — | 0.15× | ||
| Q3 25 | 1.10× | 3.55× | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
